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Aim:  The  aim  of  this  study  was  to  investigate  inﬂammatory  and  respiratory  responses  to
welding  fume  exposure  in  patients  with  suspected  occupational  asthma.
Methods:  Sixteen  patients  referred  to the  Finnish  Institute  of Occupational  Health  under-
went mild  steel  (MS)  and  stainless  steel  (SS)  welding  challenge  tests,  due  to suspicion  of
OA. Platelet  count,  leucocytes  and  their  differential  count,  hemoglobin,  sensitive  CRP, lipids,
glucose and  ﬁbrinogen  were  analyzed  in addition  to interleukin  (IL)-1,  IL-6,  IL-8,  TNF-,
endothelin-1,  and  E-selectin  in  plasma  samples.  Peak  expiratory  ﬂow  (PEF),  forced  expira-
tory volume  in  1 min  (FEV1) and  exhaled  nitric  oxide  (NO)  measurements  were  performed
before  and  after  the  challenge  test.  Personal  particle  exposure  was  assessed  using  IOM  and  a
mini  sampler.  Particle  size  distribution  was  measured  by  an  Electric  Low  Pressure  Impactor
(ELPI).
Results:  The  number  of leukocytes,  neutrophils,  and  platelets  increased  signiﬁcantly,  and
the  hemoglobin  level  and  number  of erythrocytes  decreased  signiﬁcantly  after  both  the  MS
and SS  exposure  tests.  Five  of the  patients  were  diagnosed  with  OA,  and  their  maximum  fall
in FEV1 values  was 0.70  l  (±0.32)  4 h after  SS  exposure.  MS  welding  generated  an  average
inhalable  particle  mass  concentration  of  31.6,  and  SS welding  of  40.2  mg/m3.  The  mean
particle  concentration  measured  inside  the welding  face  shields  by the mini  sampler  wasickel (PubMed CID: 935) 30.2 mg/m3 and 41.7  mg/m3, respectively.
Conclusions:  Exposure  to MS and  SS welding  fume  resulted  in  a mild  systemic  inﬂamma-
tory  response.  The  particle  concentration  from  the  breathing  zones  correlated  with  the
measurements  inside  the  welding  face  shields.
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1. IntroductionWelding is a process that joins material, usually metals
or alloys, by using heat and/or compression. Welders are
exposed to fumes containing different gases and particles,
depending on the composition of the welding electrodes,
 access article under the CC BY-NC-ND license (http://creativecommons.
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welded material, and the welding method used. Welding
particles include both ﬁne (0.1–2.5 m)  and ultraﬁne par-
ticles (< 0.1 m)  [1].
Welding fume exposure has been associated with
several adverse health outcomes such as chronic bron-
chitis, pneumonia, metal fume fever, lung function
changes, and a possible elevated risk of lung cancer
and death from ischemic heart disease [2–8]. In addi-
tion, population-based studies have shown that welders
are at an almost twofold risk of developing asthma
[9,10]. Moreover, other epidemiological studies have indi-
cated that exposure to welding fumes may  indeed be
a direct cause of asthma [11,12]. Some case series
have revealed occupational asthma (OA) in workers
exposed to stainless steel welding fumes in particular
[13–15].
The underlying mechanisms responsible for these car-
diorespiratory effects are largely unknown. One line of
research has investigated the possible association between
welding fume exposure and acute systemic inﬂamma-
tory responses [16–18]. The hypothesis is that short-term
exposure to welding fumes may  induce a local as well as
systemic inﬂammatory reaction, which may  be respon-
sible for chronic lung and cardiovascular disease if the
exposure persists for a long time [18]. In our own
recent study [19], welding fumes, as well as dusts and
fumes from sheet metal work, caused a slight acute
inﬂammation during a work shift in actual workplace con-
ditions.
The aim of the present study was to further inves-
tigate, on the basis of prior studies, whether short
exposure to high concentration of welding fumes is capa-
ble of inducing acute effects on hematological, systemic
inﬂammatory and respiratory parameters by follow-
ing welding challenge test in patients with suspected
OA.
2. Subjects and methods
2.1. Study subjects
The study consisted initially of 18 patients who  were
referred to the Finnish Institute of Occupational Health
(FIOH) by pulmonologists of local central hospitals or by
physicians of local occupational health units from all over
Finland in 2007. Sixteen of the patients had been diag-
nosed with asthma previously and two patients had asthma
like symptoms but not speciﬁc diagnosis of asthma; all
patients were suspected of having OA caused by welding
fumes. One patient was excluded from the study because
his exposure tests were not performed on consecutive days,
and another was excluded because he was given medica-
tion during the study which may  have affected the blood
results. Therefore, the ﬁnal study population comprised 16
participants. They were all male, and worked as welders
(N = 7), sheet metal workers (N = 7), assemblers (N = 1) and
metal workers (N = 1). All of them were exposed to weld-
ing fumes in their work regardless of their occupational
title. Asthma medication was discontinued before testing
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2.2. Study protocol
Welding challenge tests were performed in a special
welding chamber (6 m3). Fifteen of the participants were
exposed to mild steel (MS) (control test) and stainless steel
(SS) welding fumes on consecutive days as described ear-
lier for suspicion of OA [15]. One subject was exposed to
MS welding fumes only. The manual metal arc welding
(MMAW)  exposure time was 30 min. During the exposure,
ﬁve rods were consumed in the MS  control test (OK 48.00;
ESAB AB, Gothenburg, Sweden) and 11 rods in the ST weld-
ing test (OK 63.30; ESAB AB, Gothenburg, Sweden) [14].
OA was diagnosed according to European guidelines
[20]. Study participants were monitored for 24 h after each
challenge.
Altogether ﬁve venous blood samples (one blood sam-
ple before each of the challenge tests and one blood sample
after each of the challenge tests and the ﬁfth one on the
next day after the tests) were taken from each of the sub-
jects (Fig. 1). Baseline measurements of peak expiratory
ﬂow (PEF), forced expiratory volume in 1 min  (FEV1), and
exhaled nitric oxide (NO) were performed before MS  expo-
sure, and then approximately 22 h after the MS and SS
exposure. Each participant gave written informed consent
and ﬁlled in a questionnaire concerning work and exposure
history, smoking habits, lung and cardiovascular disease
history, and medication. The study protocol was  approved
by the Ethics Committee of the Hospital District of Helsinki
and Uusimaa.
2.3. Hematological and systemic inﬂammatory analyses
The concentrations of interleukin (IL)-1, IL-6, IL-8,
tumor necrosis factor alpha (TNF-), endothelin-1, and
E-Selectin in the plasma samples were determined by
enzyme immunoassay (EIA) using commercial reagents:
IL-1 (sensitivity 0.063 pg/ml) and TNF- (sensitivity
0.125 pg/ml), Quantikine HS ELISA, R&D Systems Europe
Ltd., Abindgon, UK; IL-6 (sensitivity 0.6 pg/ml), Peli-
Pair ELISA, Sanquin, Amsterdam, the Netherlands; IL-8
(sensitivity 1.56 pg/ml), Opt EIA, BD Biosciences, Erem-
bodegem, Belgium; endothelin-1 (sensitivity 0.68 pg/ml),
QuantiGlo ELISA, R&D Systems Europe Ltd., Abindgon, UK;
E-Selectin (sensitivity 20.5 pg/ml), ELISA, HyCult Biotech-
nology, Uden, the Netherlands).
Platelet count, leucocytes and their differential count,
hemoglobin, haematocrit, sensitive C-reactive protein
(CRP), lipids, glucose, and levels of ﬁbrinogen were ana-
lyzed using established methods.
All laboratory analyses were performed blind to the
exposure status of the studied participants.
2.4. Respiratory measurements
A portable, pocketsize spirometer (One Flow, STI MED-
ICAL, Saint-Romans, France) recorded the lung function
measurements (PEF, FEV1), and a decrease of 20% in PEF or
FEV1 from the baseline value was regarded as signiﬁcant
[21].
Exhaled NO was  measured using a chemiluminescence
gas analyzer (NIOX, Aerocrine AB, Solna, Sweden),
































abnormal plasma fasting glucose level. In addition, mean
BMI  (body mass index) was  27.5, showing mild over-
weight.
Table 1
Characteristics of participants (N = 16). Values for age, BMI, measured lab-
oratory test results, welding years, and exposure given in means with
standard deviation.
Age, years 44.6 (10.7)
BMI  27.5 (4.2)
Baseline FEV1, l 3.7 (0.47)
Baseline PEF, l/min 552 (92)
Cholesterol, mmol/l 5.5 (1.0)
HDL, mmol/l 1.3 (0.38)
Triglycerides, mg/l 1.6 (0.68)
Glucose, mmol/l 5.7 (0.49)
Diagnosed asthma 14/16
Welding, years 23.8 (13.0)
Smoking habits
Current smokers, N 1/16Fig. 1. Descrip
ccording to ATS FENO guidelines. Values of >30 ppb were
onsidered to be over normal [22].
.5. Exposure measurements
Particle exposure was assessed by personal sampling
rom the breathing zone of 14 participants. Inhalable dust
amples were collected outside welding face shields using
n IOM sampler with a cellulose acetate ﬁlter (AAWP, diam-
ter 25 mm;  Millipore, Bedford, MA,  USA). Sampling time
as 30 min  and volumetric ﬂow was adjusted to 2.0 l/min.
he samples were analyzed gravimetrically [23].
In addition, mini sampler measurements were car-
ied out simultaneously with the IOM sampling [24]. The
ini samples were collected from inside the welding face
hields of the 15 participants. The sampling volumetric
ow was 0.75 l/min and the sampling time 30 min. Dust
amples were analyzed gravimetrically.
During the MS  and SS welding exposure tests of three
articipants, particle number size distributions were mea-
ured by an Electric Low Pressure Impactor (ELPI) (Dekati
td., Finland) in a size range of 30 nm to 10 m.  The ELPI
easurement system gives particulate number concentra-
ions in 12 size bins covering the whole measurement size
ange.
.6. Statistical analyses
Repeated data consisted of the results of inﬂammatory
esponses during the exposure in the welding chamber. All
esponse variables were continuous and mostly normally
istributed. Therefore, the paired t-test was applied when
omparing the values before and after a challange test. If the
ariable was non-normally distributed, the Wilcoxon one
ample test was used. A P-value of <0.05 was set to indi-
ate statistical signiﬁcance. All analyses were performed
sing the Statistical Analysis System, SAS Version 9.1 (SAS
nstitute Inc., Cary, NC, USA).tudy protocol.
3. Results
3.1. Study population characteristics
The mean age of the 16 study participants was 44.6
(range 23–57 years), and they were all men  (Table 1).
Average work history was 27.5 years of welding. One
(6%) was  a current smoker, eight (50%) were ex-smokers,
and seven (44%) had never smoked regularly. Fourteen
of the patients had been diagnosed with asthma previ-
ously and two patients had asthma like symptoms but not
speciﬁc diagnosis of asthma; three patients had hyperten-
sion.
The average serum cholesterol level and plasma fas-
ting glucose level were high in the total study group. As
much as 75% (N = 12) had an elevated level of total serum
cholesterol, 31% (N = 5) of triglycerides and 19% (N = 3) ofEx-smokers, N 8/16
Non-smokers, N 7/16
BMI: body mass index; FEV1: forced expiratory volume in 1 min; PEF: peak
expiratory ﬂow; HDL: high density lipoprotein
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3.2. Hematological and systemic inﬂammatory markers
After the MS  exposure test, hemoglobin level decreased
signiﬁcantly from 157 g/l to 154 g/l and the number of
erythrocytes from 5.0 to 4.9 (1012 cells L−1), whereas the
number of leukocytes increased signiﬁcantly from 6.5 to 7.4
(109 cells L−1), neutrophils from 3.7 to 4.4 (109 cells L−1),
and platelets from 273 to 291 (109 cells L−1) (Table 2). Sim-
ilar statistically signiﬁcant changes were found following
the SS exposure test. Of the systemic immune parameters,
the concentration of E-selectin decreased signiﬁcantly, but
only in the MS  exposure test (from 48.7 to 46.2 ng/ml)
(Table 2).
3.3. Respiratory function
The base level of exhaled nitric oxide was elevated
(>30 ppb) in ﬁve participants (31%). There were no statisti-
cally signiﬁcant changes 22 h after the welding exposure
tests (Table 3). However, exhaled NO concentration
increased by over 30% in ﬁve study participants after the MS
exposure test, and in two participants after the SS exposure
test compared to the base level measured before the ﬁrst
exposure test. There were slight and statistically signiﬁcant
reductions in the FEV1 (mean FEV1 3.74 l in the baseline and
3.65 l after MS  (P 0.032) and 3.59 l (P 0.26) after SS weld-
ing) and PEF values. Respectively, the mean PEF value was
566 l/min at the baseline, 543 l/min after MS  (P 0.017) and
529 l/min (P 0.022) 22 h after SS welding tests.
Five participants had a positive reaction (a decrease of
20% of PEF or FEV1 from baseline value) in the SS chal-
lenge test and were therefore diagnosed with OA. In the
Table 2
Inﬂammatory and hematological parameters before and after welding exposure t
Blood parameters Day 1, mild steel exposure MS (N = 16) Day 2, stai
Before After P Before 
Hemoglobin, g/l 157 ± 12.8 154 ± 11.7 0.016 158 ± 12
Leukocytes,
109 cells L−1
6.5 ± 1.2 7.4 ± 1.5 0.009 6.7 ± 0.9
Neutrophils,
109 cells L−1
3.7 ± 1.2 4.4 ± 1.3 0.002 3.8 ± 0.9
Lymphocytes,
109 cells L−1
2.2 ± 0.66 2.2 ± 0.45 ns 2.3 ± 0.5
Eosinophils,
109 cells L−1
0.20 ± 0.09 0.16 ± 0.09 0.012 0.25 ± 0.0
Erytrocytes,
1012 cells L−1
5.0 ± 0.38 4.9 ± 0.34 0.013 5.0 ± 0.3
Monocytes,
109 cells L−1
0.40 ± 0.11 0.51 ± 0.15 0.012 0.38 ± 0.0
Basophils,
109 cells L−1
0.03 ± 0.05 0.06 ± 0.05 ns 0.04 ± 0.0
Platelet count,
109 cells L−1
273 ± 62.5 291 ± 61.3 <0.001 282 ± 57
Sensitive CRP,
mg/ml
1.46 + 2.24 1.51 + 2.25 ns 1.58 + 2.2
P-ﬁbrinogen, g/l 3.4 ± 0.98 3.1 ± 0.93 ns 3.4 ± 0.9
IL-1,  pg/ml 0.57 ± 0.43 0.45 ± 0.30 ns 0.65 ± 0.8
IL-6,  pg/ml 2.7 ± 1.6 2.5 ± 1.6 ns 2.5 ± 1.4
IL-8,  pg/ml 7.7 ± 2.8 7.2 ± 3.6 ns 8.3 ± 4.8
TNF-,  pg/ml 2.0 ± 0.68 2.0 ± 0.83 ns 2.1 ± 1.1
Endotelin 1, pg/ml 0.92 ± 0.23 0.86 ± 0.22 ns 0.87 ± 0.2
E-selectin, ng/ml 48.7 ± 20.9 46.2 ± 19.1 0.04 47.2 ± 19
Comparison 5–1: comparison of Blood test 5 on Day 3, and of Blood test 1 on Dayorts 2 (2015) 357–364
rest of the patients (N = 11), the ﬁnal diagnoses after the
examinations at the FIOH were asthma (N = 9), asthma like
symptoms (N = 1) and chronic obstructive pulmonary dis-
ease (N = 1). In the patients with OA (N = 5), the average
FEV1 value was 4.0 l (±0.38) and the PEF value 617 l/min
(±100) before the welding challenge tests. The maximum
fall in the FEV1 and PEF values was 0.70 l (±0.32) and
140 l/min (±62), respectively, 4 h after SS exposure. In par-
ticipants with no conﬁrmed OA (N = 11), leucocytes and
neutrophils increased signiﬁcantly, whereas erythrocytes
decreased signiﬁcantly following both the welding chal-
lenge tests (Table 4). In participants with conﬁrmed OA,
only platelet count increased signiﬁcantly, from 273 ± 76.5
to 288 ± 83.0 after the MS  exposure test (P 0.014), and
from 290 ± 81.9 to 304 ± 77.3 after the SS exposure test (P
0.014).
3.4. Particle exposure
Particle concentration measured in the breathing zone
of 14 participants by the IOM sampler varied from 12.7 to
79.4 mg/m3 in the MS  and from 15.9 to 100 mg/m3 in the
SS exposure tests. The average particle concentrations were
31.6 and 40.2 mg/m3, respectively. The mean particle con-
centration measured inside the welding face shields by the
mini sampler was  30.2 mg/m3 in the MS  exposure tests, and
41.7 mg/m3 in the SS exposure tests. Compared to the IOM
results, the particle concentration measured by the mini
sampler was  4.4% lower in the MS  and 3.7% higher in SS
exposure tests.
Fig. 2 presents the particle number size distributions in
the MS  and SS exposures of one participant. Particle size
ests.
nless steel exposure SS (N = 15) Blood sample 5 Comparison 5–1
After P Mean (±SD) P
.0 155 ± 12.3 0.019 157 ± 11.3 n.s
9 7.8 ± 1.6 0.004 6.7 ± 0.9 n.s.
4 4.8 ± 1.4 0.004 3.9 ± 1.0 n.s.
6 2.3 ± 0.46 ns 2.1 ± 0.64 n.s.
9 0.20 ± 0.09 0.022 0.23 ± 0.11 0.025
4 4.9 ± 0.31 0.008 4.9 ± 0.32 n.s.
8 0.56 ± 0.20 <0.001 0.37 ± 0.13 n.s.
5 0.06 ± 0.05 ns 0.04 ± 0.05 n.s.
.3 293 ± 59.9 0.008 278 ± 52.4 n.s.
1 1.60 + 2.14 ns 1.46 ± 2.24 n.s.
1 3.5 ± 1.1 ns 3.6 ± 1.01 n.s.
6 0.65 ± 0.76 ns 0.46 ± 0.30 n.s.
 2.4 ± 1.1 ns 2.6 ± 1.4 n.s.
 7.4 ± 2.7 ns 7.4 ± 3.3 n.s.
 1.8 ± 0.53 ns 1.8 ± 0.6 n.s.
1 0.88 ± 0.35 ns 0.90 ± 0.26 n.s.
.2 47.3 ± 20.2 ns 45.9 ± 19.8 n.s.
 1.
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Table  3
Average exhaled nitric oxide (NO), FEV1 and PEF values with standard deviation (SD) before and after exposure tests.
Before exposure tests
(N = 16)
After mild steel exposure
(N = 16)
After stainless steel exposure
(N = 15)
Mean (SD) Range Mean (SD) Range Mean (SD) Range
Exhaled NO, ppb 25 (22) 4.9–74 25 (24) 4.5–79 28 (27) 6.2–86
FEV1, l 3.74 (0.47) 3.65 (0.46) 3.59 (0.48)
PEF,  l/min 566 (92) 543 (79) 529 (87)
FEV1: forced expiratory volume in 1 min; PEF: peak expiratory ﬂow.
Table 4
Inﬂammatory blood parameters before and after welding exposure tests on participants with no conﬁrmed occupational asthma.
Day 1, mild steel exposure (N = 11) Day 2, stainless steel exposure (N = 10)
Before After P Before After P
Hemoglobin, g/l 159 ± 13.3 156 ± 11.6 0.031 159 ± 12.8 156 ± 13.8 ns
Leukocytes, 109 cells L−1 6.6 ± 1.4 7.5 ± 1.5 0.030 6.7 ± 0.81 8.2 ± 1.7 0.001
Neutrophils, 109 cells L−1 3.4 ± 1.4 4.5 ± 1.4 0.003 3.7 ± 1.02 5.0 ± 1.7 0.002
Lymphocytes, 109 cells L−1 2.4 ± 0.68 2.3 ± 0.37 ns 2.4 ± 0.48 2.4 ± 0.39 ns
Eosinophils 109 cells L−1 0.21 ± 0.09 0.17 ± 0.10 0.017 0.27 ± 0.10 0.23 ± 0.08 ns












tMonocytes, 109 cells L−1 0.41 ± 0.13 0.48 ± 0.13
Basophils, 109 cells L−1 0.05 ± 0.05 0.06 ± 0.05
Platelet count, 109 cells L−1 274 ± 59.4 292 ± 53.6
istribution was very similar in both exposures. Total parti-
le number concentration in SS welding was 3.2 × 106 cm−3
nd in MS  welding 1.7 × 106 cm−3. SS welding generated
 higher particle number concentration, presumably due
o the higher rod number consumption than in MS  weld-
ng. In both exposure tests, most of the welding fume
articles were smaller than 1 m.  The middle point of
he mode was around 430 nm in both welding challenge
ests.
Fig. 2. Particle number size distribution in one participant’s m0.030 0.37 ± 0.09 0.54 ± 0.19 0.010
ns 0.05 ± 0.05 0.08 ± 0.04 ns
0.008 278 ± 46.8 288 ± 53.1 ns
4. Discussion
Systemic inﬂammatory, hematological and respiratory
responses were studied in 16 middle-aged male workers
exposed to welding fumes and of whom 14 had asthma, one
chronic obstructive pulmonary disease and one had asthma
like symptoms. Previous studies on this subject have been
epidemiological [11,12,25,26], carried out on healthy vol-
unteers [16–18] or in workplace settings [19,27]. This is
ild steel (MS) and stainless steel (SS) exposure tests.
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the ﬁrst study to report the systemic inﬂammatory and
hematological responses in patients with asthma.
Blood leukocytes and neutrophils increased signiﬁ-
cantly following both the MS  and the SS welding exposure
tests. This is consistent with other studies dealing with the
acute effects of welding exposure [17–19]. Peripheral blood
neutrophilia has also been found following short-term
inhalation exposure to other substances, such as ozone [28]
and compost dust [29].
Blood platelets increased signiﬁcantly after both the
MS and SS welding challenges. This ﬁnding contradicts
those of Hartmann et al. [18] and those we  ourselves
have previously reported [19]. The fact that these present
observations could be seen as being at odds with these
prior ﬁndings might also be due to differences in expo-
sure characteristics. In the former study, the participants
were exposed to fumes of metal-inert-gas (MIG) weld-
ing of aluminum and MIG  soldering of zinc-coated steel
and, in the latter study, to MS  welding fumes and to
dusts and fumes generated from grinding MS  plates
or pieces. In addition, there was a tenfold difference
between the average particle concentrations in the ear-
lier studies and those in the present study. Increased
platelet count in peripheral blood has previously been
reported as also occurring after inhalation of diesel exhaust
[30]. Another reason could be reactive thrombocytosis
due to increased inﬂammation or bone marrow stimula-
tion.
Hemoglobin and erythrocyte levels decreased signiﬁ-
cantly following both the MS  and SS welding exposure
tests, which is consistent with our earlier ﬁndings [19].
Although this ﬁnding has not been observed in other
studies dealing with the acute effects of welding fumes
[17,18], a signiﬁcant association between the concentra-
tion of particulate matter (PM10) and blood hemoglobin
levels has been reported by Seaton et al. [31]. It is unclear
how ﬁne particulate matter exposure leads to changes in
hemoglobin or erythrocyte levels, but it has been specu-
lated that this could be due to a combination of mechanisms
such as volume status or stress, which could affect blood
viscosity [30]. As a possible mechanism, Seaton et al. sug-
gested that the inhalation of some component of PM10
may  cause the sequestration of red cells in circulation
[31]. In our prior study, the decrease in hemoglobin lev-
els may  have been caused by differences in metabolic
intensity and ﬂuid shifts during moderate- or low-level
physical work [19]. Our present results could also be inﬂu-
enced by these factors, although the welding was not as
physically demanding as welding in actual workplace con-
ditions.
Taken together, our peripheral blood ﬁndings (the
increased level of blood leukocytes, neutrophils, and
platelets, and the decreased level of hemoglobin and eryth-
rocytes) are in line with the suggestion that a mild systemic
inﬂammatory response takes place during welding expo-
sure [16,17,19]. This response was a time-limited process,
because 22 h after the last exposure test, the response was
attenuated.
The present study observed no statistical differences in
CRP levels, which is in accordance with our earlier results
[19]. In general, the available data on this subject is mixed,orts 2 (2015) 357–364
since some of the studies support signiﬁcant CRP changes
related to welding fume exposure [17,29] while others do
not [16,19]. This inconclusive situation demands further
investigation. No statistical differences in the concentra-
tions of acute-phase mediators such as TNF-, IL-6 and IL-8
have been reported in humans following welding exposure
[16,19]. We  also found no statistical differences in the lev-
els of these cytokines, and therefore, our current ﬁndings
conﬁrm previous observations.
The levels of IL-1, which is a proinﬂammatory
cytokine, in relation to welding have thus far only been
studied once [19]. The study found that IL-1 levels
decreased signiﬁcantly, which was  unexpected. In the
present study, no signiﬁcant changes were observed in IL-
1 levels. E-selectin levels in relation to welding have also
only been studied once to date [18]. In our previous study,
the E-selectin level decreased signiﬁcantly, which was also
observed in the present study, but only following expo-
sure to the MS  welding fumes. We  also studied the levels
of endothelin-1, which is a vasoconstrictor peptide, and
ﬁbrinogen, which is a soluble plasmaprotein, but found no
signiﬁcant changes in either, which is in accordance with
previous reports [16,18,19].
Exposure to welding fumes has been associated with
reduced pulmonary function [25–27] and asthma [9,10,11].
It has been suggested that changes in welders’ lung func-
tions are transient, occurring at the time of exposure at the
workplace and returning to normal during non-exposed
periods. Welding fumes of stainless steel can cause OA
[13,15]. In this study we found ﬁve cases of OA, and
these individuals showed marked late phase changes in
pulmonary function (FEV1, PEF) in response to the SS
welding challenge test. Interestingly, signiﬁcant changes in
hematological parameters were found in non-occupational
asthma patients but not in patients with conﬁrmed OA.
Behndig et al. reported parallel ﬁndings in their study,
in which both asthma patients and healthy individuals
were exposed to diesel exhaust particles or ﬁltered air.
They observed a signiﬁcant increase of submucosal neu-
trophils and of neutrophil numbers in the bronchial wash
of the healthy participants but not among the asthmatics
[32].
SS welding generated a higher particle mass and num-
ber concentration, presumably due to the higher rod
number consumption than that in MS  welding. In both
exposure tests, most of the welding fume particles were
smaller than 1 m,  and the particle size distribution was
similar in both exposures. The average welding fume
exposure in challenge tests was  high, but similar high
momentary exposures can also occur in workplace condi-
tions. The measured particle mass range was  quite wide,
depending mostly on the participant’s working method.
Some participants were bent very close to the object being
welded, therefore their breathing zone particle concen-
trations were higher than those of the participants who
were at a longer working distance from the object being
welded. The fumes generated during mild steel weld-
ing contain mainly iron (80–95%) and also manganese
(1–15%), whereas stainless steel welding produces smaller
amounts of these but high amounts of chromium (15–30%)
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omposition of the fumes generated in the challenge tests
n the present series, but we have done this previously [33].
hese published results are in line with those published in
he literature.
The strength of our study was the possibility to
bjectively monitor both the welding exposure and the
nﬂammatory, hematological and respiratory responses at
he individual level. The limitations of the study were the
ack of an unexposed control group and the relatively small
umber of participants. Since the welding challenge tests
n the laboratory environment were the only procedures
ith the study individuals during the days, there is no
ther explanation for the slight inﬂammatory response
ven in the lack of unexposed control group. The study
articipants stayed at the FIOH during the test days and
hus work, exercise, or other environmental factors can-
ot be used as an explanation. Also, the results are in
ine with our previous study on welding in an occupa-
ional/workplace setting [19]. Furthermore, a larger study
roup would probably have given more signiﬁcant results,
ather than diminish the ﬁndings. The presence of Cr and
i in the fumes may  cause lung injury and inﬂammation,
ung tumor formation, immune dysfunction, and systemic
oxicity [34]. However, welding processes produce fumes
onsisting of gaseous and aerosol by-products composed of
etals, metal oxides and volatilized chemical species from
he base metals, welding electrode, or ﬂux material [1]. In
he present study, we could not elucidate which compo-
ent of the welding fumes was responsible for the observed
ndings.
We cannot exclude that performing the exposure tests
n consecutive days could have affected the results. Unfor-
unately, there is no worldwide consensus how welding
xposure tests should be performed. However, the situ-
tion could be better in the future, because suggestions
ave been published how experimental welding fume
xposure studies under controlled and standardized con-
itions should be carried out ([35]). The used welding
hallenge tests in our series have been standardized [15].
he challenge tests are the “golden standard” for diag-
osing OA. The procedure includes ﬁrst the placebo test
nd the active test second. It is important that the time
etween the two tests should be minimized since the
atients cease their asthma medication, and the longer the
eriod between the two tests is the less comparable the
est results are. Furthermore, keeping an asthma patient
ithout regular asthma medication for several days would
rovoke unspeciﬁc asthma symptoms and false positive
est results.
.1. Conclusions
In conclusion, we observed a mild systemic inﬂamma-
ory response following welding fume challenge tests. An
ncrease was observed in peripheral blood leukocytes, neu-
rophils, and platelets, and a decrease in hemoglobin level
nd in erythrocyte count. The particle size distribution of
elding fumes was similar regardless of the exposure;
ost of the welding fume particles were smaller than 1 m,
nd the IOM measurements correlated well with the mini
ampler measurements.
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